Table 2

Measures for prevention/monitoring of osteoporosis among individuals at increased risk (figures are percentages)

Individuals at increased risk*
n=1469
At least one measure during the year following treatment initiation61.5
 Dual-energy X-ray absorptiometry12.9
 Drugs for osteoporosis management60.6
  Vitamin D ± calcium54.2
  Bisphosphonates27.4
   Bisphosphonates20.8
   Fixed association of bisphosphonates and vitamin D ± calcium9.1
  Other drugs for osteoporosis management5.0
   Calcitonin0.7
   Denosumab0.3
   Raloxifene0.6
   Strontium ranelate3.1
   Teriparatide0.6
  • *At least six reimbursements of oral glucocorticoids per year and (1) age ≥70 years or (2) history of untreated osteoporosis.